With a worldwide distribution of approximately 10,000, Wavelength is Elekta’s semi-annual global publication with a readership comprised mainly of Elekta users, including radiation oncologists, neurosurgeons, physicists, dosimetrists, therapists and administrators. Each issue of Wavelength contains feature articles that highlight, through personal interviews, how users employ their Elekta cancer management solutions to benefit their patients. Clinical solution areas are Oncology, Neuroscience, Software and Brachytherapy. Also covered in Wavelength are news items on product introductions and upgrades, Elekta acquisitions, interviews of company executives, research and development, user meetings, events, education and training opportunities, product service, company awards and new Elekta users.